Aseptic sterile connections and flexible-tubing handling in cell therapy manufacturing

Autologous and allogeneic cell therapy production strings together many fluid-transfer steps between culture bags, bioreactors, reagent vials and sampling devices, and these connections are made by mating sterile luer/needle-free connectors or by tube welding, then routing soft compliant tubing without kinking or breaching sterility. The objects are flexible polymer tubing, deformable single-use culture bags and small connectors, all variable in geometry and easily damaged. This sits at the heart of 'closed' processing that moves operations out from under a biosafety cabinet; it is one of the most manual, artisanal stages of the workflow and is precisely where contamination risk concentrates. It is hard for a robot because success depends on feeling tubing compliance, applying graded force to seat a connector to an audible/tactile click, and confirming a leak-free aseptic seal that no camera can verify. AstraZeneca's Multiply Labs collaboration and its new Rockville cell therapy site make this an active automation target. We identified this through our own research; we have not confirmed the specifics with the customer directly. This page is our researched read — a starting point for that conversation.